Kayla Goliwas, PhD

Kayla Goliwas, PhD

University of Alabama at Birmingham

Research Project:
Combining Immune Checkpoint Therapy and Interlukin-6 Targeting to Enhance the Anti-Tumor Immune Response

Grant Awarded:

  • Catalyst Award

Research Topic:

  • immunology immunotherapy

Research Disease:

  • lung cancer

Treatment of non-small cell lung cancer continues to be a major clinical challenge. A new combination of therapies targeting infiltrating immune suppressive cells, which promote tumor progression, may increase the body’s anti-tumor immune response. Therefore, this treatment strategy is of great interest. This study aims to evaluate the potential to combine current clinically utilized immune directed therapy with inhibition of one pathway involved in the accumulation of immune suppressive cells within the tumor, interleukin-6 signaling, to increase therapeutic effect.

Page last updated: January 26, 2023

Freedom From Smoking Clinic
Gladwin, MI | Apr 03, 2023
COPD Educator Course
, | Apr 12, 2023